Calcutta HC Denies Abhishek Banerjee Immediate Relief in DJ Remark Voice Sample Case  ||  Bombay High Court Grants Bombay Group Relief in Vadilal Dispute Against Ahmedabad Group  ||  Kerala HC Orders Time-Bound Disposal of Prisoners' Remission Pleas, Mandates NALSA SOP Compliance  ||  Delhi HC Rejects Plea of Two Army Doctors Seeking NEET PG 2026 Exam Amid Eligibility Rule Challenge  ||  Jharkhand HC: Mother Cannot Consent to a Major Son's DNA Test During a Pending Matrimonial Case  ||  Bombay HC Rules on Whether Arrest is Illegal if Co-Accused Charge Sheet is Not Supplied Earlier  ||  Gujarat HC: State Cannot Indefinitely Reserve Private Land Without Acquisition or Plan Revision  ||  Chhattisgarh HC: Complaints Without Disciplinary Action Cannot Affect a Judge's Seniority  ||  Delhi HC Upholds Selection of India's Dressage Team For the 2026 Asian Games  ||  MP High Court Orders State to Airlift Gas Pipeline Blast Victim to Ahmedabad For Treatment    

U.S. PTO Rules in Favour of Mylan - (29 Aug 2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to multiple sclerosis drug Copaxone.

Tags : U.S.PATENT AND TRADEMARK OFFICE   NATCO PHARMA   PATENT CLAIMS  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved